% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • fantomen99 fantomen99 Sep 6, 2011 9:01 AM Flag

    Primary listing to Stockholm Exchange

    EpiCept: Moves the share of primary listing to Stockholm

    Biotechnology Company Epicept move its primary listing of shares to
    the Stockholm Stock Exchange, effective today, September 5.

    The share was previously a secondary listing on the Stockholm Stock Exchange.

    It appears from a stock exchange release.

    EpiCept is also listed on Nasdaq. The Company do however currently not comply with the Nasdaq requirements for a minimum share price of $ 1.

    Henry Öhlin, +46 31 350 64 87
    henrik.ohlin @
    SIX News

    strange, this information is hard to find in the U.S

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.66-0.05(-2.92%)Jul 31 3:59 PMEDT